RISK OF OESOPHAGEAL ADENOCARCINOMA IN NON-DYSPLASTIC BARRETT'S OESOPHAGUS

被引：0
|
作者：
Allam, M. M. [1 ]
Murray, G. [2 ]
Phull, P. [3 ]
机构：
[1] Univ Aberdeen, Med Sch, Aberdeen, Scotland
[2] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Digest Disorders, Aberdeen, Scotland
来源：
GUT | 2017年 / 66卷
关键词：
D O I：
10.1136/gutjnl-2017-314472.377
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PWE-132
引用
收藏
页码：A193 / A194
页数：3
相关论文
共 50 条
  • [41] Non-Dysplastic Barrett's Surveillance: As Recommendations Evolve, Do We?
    Brown, Craig
    Ujiki, Michael
    Lapin, Brittany
    Wang, Chi
    Linn, John
    Denham, Woody
    Haggerty, Stephen
    Carbray, Joann
    Talamonti, Mark
    Howington, John
    Goldstein, Jay
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S656 - S656
  • [42] Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma
    Barclay, JY
    Morris, A
    Nwokolo, CU
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) : 221 - 227
  • [43] What Is the Optimal Surveillance Strategy for Non-dysplastic Barrett’s Esophagus?
    Ying Gibbens
    Prasad G. Iyer
    [J]. Current Treatment Options in Gastroenterology, 2020, 18 (3) : 369 - 383
  • [44] Does a prior diagnosis of Barrett's oesophagus influence risk of dying from oesophageal adenocarcinoma?
    Whiteman, David C.
    [J]. GUT, 2015, 64 (01) : 5 - U248
  • [45] Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma
    Buas, Matthew F.
    He, Qianchuan
    Johnson, Lisa G.
    Onstad, Lynn
    Levine, David M.
    Thrift, Aaron P.
    Gharahkhani, Puya
    Palles, Claire
    Lagergren, Jesper
    Fitzgerald, Rebecca C.
    Ye, Weimin
    Caldas, Carlos
    Bird, Nigel C.
    Shaheen, Nicholas J.
    Bernstein, Leslie
    Gammon, Marilie D.
    Wu, Anna H.
    Hardie, Laura J.
    Pharoah, Paul D.
    Liu, Geoffrey
    Iyer, Prassad
    Corley, Douglas A.
    Risch, Harvey A.
    Chow, Wong-Ho
    Prenen, Hans
    Chegwidden, Laura
    Love, Sharon
    Attwood, Stephen
    Moayyedi, Paul
    MacDonald, David
    Harrison, Rebecca
    Watson, Peter
    Barr, Hugh
    deCaestecker, John
    Tomlinson, Ian
    Jankowski, Janusz
    Whiteman, David C.
    MacGregor, Stuart
    Vaughan, Thomas L.
    Madeleine, Margaret M.
    [J]. GUT, 2017, 66 (10) : 1739 - 1747
  • [46] GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma
    Pavlov, Kirill
    Honing, Judith
    Meijer, Coby
    Boersma-van Ek, Wytske
    Peters, Frans T. M.
    van den Berg, Anke
    Karrenbeld, Arend
    Plukker, John T. M.
    Kruyt, Frank A. E.
    Kleibeuker, Jan H.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 (01) : 73 - 80
  • [47] The role of DNA damage in the development of Barrett's oesophagus and oesophageal adenocarcinoma
    Olliver, JR
    Hardie, LJ
    Clark, GWB
    Dexter, S
    Chalmers, D
    Wild, CP
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S51 - S52
  • [48] Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications
    Ladanchuk, Todd C.
    Johnston, Brian T.
    Murray, Liam J.
    Anderson, Lesley A.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (12) : 1397 - 1403
  • [49] ADHERENCE TO GUIDELINES FOR SURVEILLANCE AND CHEMOPREVENTION OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS
    Khan, Tanya
    Kraft, Cary
    Leet, Donna
    Libuit, Erin
    Xu, Chelsea
    Dalal, Nicole
    Pierce, Logan
    Ravi, Akshay
    Ko, Myung S.
    Kathpalia, Priya
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S514 - S515
  • [50] THE INFLUENCE OF SOCIAL CLASS ON PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
    Bhattacharjee, S.
    Caygill, C. P. J.
    Gatenby, P. A. C.
    Watson, A.
    [J]. GUT, 2016, 65 : A135 - A135
12345